Hbk Investments L P Insmed Inc Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$20.0 - $29.72 $1.72 Million - $2.55 Million	-85,952 Reduced 87.48%	12,300 $291,000
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $1.13 Million - $1.71 Million	51,977 Added 112.32%	98,252 $2.21 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $1.22 Million - $1.47 Million	-46,140 Reduced 49.93%	46,275 $1.44 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $1.07 Million - $2.88 Million	92,415	92,415 $2.88 Million

465

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.